Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Corey

Showing results (321-330 of 511) with videos related to

Pageof 52
Sort By:
Journal of Empirical Research on Human Research Ethics : JERHRE|August 19, 2015
Key Stakeholders' Perceptions of Motivators for Research Participation Among Individuals Who Are IncarceratedBridget L Hanson, Sherilyn A Faulkner, Christiane Brems, et al.
The Journal of Infectious Diseases|February 1, 1991
Pharmacokinetic disposition of zidovudine during pregnancyD H Watts, Z A Brown, T Tartaglione, et al.
JAMA|September 9, 1988
The association between genital ulcer disease and acquisition of HIV infection in homosexual menW E Stamm, H H Handsfield, A M Rompalo, et al.
AIDS (London, England)|November 14, 1998
Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM)S R Tabet, M R Krone, M A Paradise, et al.
The Journal of Clinical Investigation|April 29, 1998
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytesD M Koelle, C M Posavad, G R Barnum, et al.
American Journal of Clinical Pathology|February 1, 1992
Interference of recombinant soluble CD4 immunoglobulin G in flow cytometric measurement of CD4+ lymphocytesP G Kidd, G D Austin, A C Collier, et al.
Vaccine|February 10, 2009
Use of predictive markers of HIV disease progression in vaccine trialsS Gurunathan, R El Habib, L Baglyos, et al.
The Journal of Infectious Diseases|April 1, 1990
Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infectionG J Mertz, R Ashley, R L Burke, et al.
Pediatric Blood & Cancer|October 14, 2004
Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapyAndrew M Davidoff, Bethany L Corey, Fredric A Hoffer, et al.
The New England Journal of Medicine|March 23, 2000
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive personsA Wald, J Zeh, S Selke, et al.
Pageof 52

Showing results (321-330 of 511) with videos related to

Sort By:
Pageof 52
Journal of Empirical Research on Human Research Ethics : JERHRE|August 19, 2015
Key Stakeholders' Perceptions of Motivators for Research Participation Among Individuals Who Are IncarceratedBridget L Hanson, Sherilyn A Faulkner, Christiane Brems, et al.
The Journal of Infectious Diseases|February 1, 1991
Pharmacokinetic disposition of zidovudine during pregnancyD H Watts, Z A Brown, T Tartaglione, et al.
JAMA|September 9, 1988
The association between genital ulcer disease and acquisition of HIV infection in homosexual menW E Stamm, H H Handsfield, A M Rompalo, et al.
AIDS (London, England)|November 14, 1998
Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM)S R Tabet, M R Krone, M A Paradise, et al.
The Journal of Clinical Investigation|April 29, 1998
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytesD M Koelle, C M Posavad, G R Barnum, et al.
American Journal of Clinical Pathology|February 1, 1992
Interference of recombinant soluble CD4 immunoglobulin G in flow cytometric measurement of CD4+ lymphocytesP G Kidd, G D Austin, A C Collier, et al.
Vaccine|February 10, 2009
Use of predictive markers of HIV disease progression in vaccine trialsS Gurunathan, R El Habib, L Baglyos, et al.
The Journal of Infectious Diseases|April 1, 1990
Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infectionG J Mertz, R Ashley, R L Burke, et al.
Pediatric Blood & Cancer|October 14, 2004
Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapyAndrew M Davidoff, Bethany L Corey, Fredric A Hoffer, et al.
The New England Journal of Medicine|March 23, 2000
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive personsA Wald, J Zeh, S Selke, et al.
Pageof 52